Table 4.
Between-study effects comparison of outcomes*
| Lymphedema effectiveness outcomes | Cumulative incidence ratio or mean difference (95% CI) between SABC and efficacy RCT | P |
|---|---|---|
| Arm volume, % interlimb difference | ||
| No. of symptoms | 0.11 (−0.42 to 0.63) | .69 |
| Severity of symptoms | 0.04 (−0.21 to 0.29) | .76 |
| Lymphedema safety outcomes | ||
| New lymphedema onset | 0.75 (0.24 to 1.38) | .63 |
| Flare-up of existing lymphedema | 1.37 (0.50 to 3.78) | .54 |
| Muscular strength outcomes | ||
| Bench press, lbs. | 4.6 (0.2 to 9.0) | .04 |
| Leg press, lbs. | 26.7 (12.0 to 41.5) | <.001 |
| Body image and relationships | ||
| Strength and health | −0.49 (−2.66 to 1.67) | .65 |
| Social barriers | −0.73 (−2.26 to 0.80) | .35 |
| Appearance and sexuality | −0.16 (−1.93 to 1.61) | .86 |
| Total score | −1.14 (−5.77 to 3.47) | .62 |
* CI = confidence interval; RCT = randomized controlled trial; SABC = Strength After Breast Cancer.